On Wednesday, Shares of Starbucks Corporation (NASDAQ:SBUX), subtract -0.34% and closed at $53.35 in the last trading session. The last trading range of the stock ranges between $53.28 and $53.76. The company’s Market capitalization is $77.79 Billion with the total Outstanding Shares of 1.47 billion. Starbucks (SBUX) recently opened its first store in Englewood in the South Side of Chicago at 63rd and Halsted. The store is part of Starbucks nationwide program to support local economic development in at least 15 diverse, low- to- medium-income communities by 2018. Three such locations have already opened in Ferguson, Phoenix and the Jamaica neighborhood of Queens, NY. Similar to those stores, the new location in Englewood will support efforts to revitalize the community by creating meaningful local jobs, providing an exclusive in-store job skills training program for youth, and investing in local minority-owned contractors and suppliers. Starbucks also declared plans to expand the national program to five new communities in 2017, counting neighborhoods in the Baltimore, Birmingham, Long Beach, CA, Miami, and Seattle areas.
“While communities like Englewood have been plagued by crime, poverty, and a severe lack of opportunity, there is in fact a long-term movement underway to revitalize these neighborhoods and return the story to one of hope, resilience and progress,” said Rodney Hines, director for community investments for Starbucks U.S. Retail Operations. “Our aim with this program is to show that when the private and public sectors come together to drive meaningful investment, we can create new jobs and economic opportunities that have the potential to reverberate for generations to come. Opening in Englewood is not just an opportunity to grow our business, but to be part of a local solution for social change.”
Lowe’s Companies, Inc. (NYSE:LOW), dropped -0.62% and closed at $72.25 in the last trading session. The last trading range of the stock ranges between $72.21 and $73.22. The company’s Market capitalization is $63.64 Billion with the total Outstanding Shares of 874.66 Million. Lowe’s Companies Inc. declared it has named Bio-Lab, Kichler and Spartanburg Forest Products as the company’s 2016 Vendor Partners of the Year. The companies were selected for their commitment to product quality, innovation and customer service.
After entering into a planned partnership with Bio-Lab to launch the first major national brand in pool chemicals, Lowe’s became the exclusive home-channel retailer of Clorox. The two companies have worked together to solve for the unique challenges that pool chemicals present in packaging, shipping and handling throughout the supply chain.
Kichler offers product across the fashion lighting category and has supported Lowe’s by expanding their existing warehouses and opening an additional facility to successfully manage their own supply chain in order to provide customers with a greater selection in a faster timeframe. Kichler also worked closely with Lowe’s to expand its digital footprint by offering its entire showroom selection on Lowes.com and developing an in-store app featuring inspiring imagery and how-to videos.
Baxter International Inc (NYSE:BAX), jumped 1.33% and closed at $47.92 in the last trading session. The last trading range of the stock ranges between $47.36 and $47.94. During the 52-week trading session the minimum price at which share price traded, registered at $32.18 and reached to max level of $49.49. Baxter International Inc. (BAX) will host a quarterly conference call to discuss its third quarter 2016 financial results on Tuesday, October 25, 2016, at 7:30 a.m. Central Time. To access the call, dial 844.886.1929 (domestic) or 225.239.4663 (international). Please dial into the call at least ten minutes before the start for the operator to connect you. The conference ID is 40543650.
Baxter provides a broad portfolio of essential renal and hospital products, counting home, acute and in-center dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition; biosurgery products and anesthetics; and pharmacy automation, software and services. The company’s global footprint and the critical nature of its products and services play a key role in expanding access to healthcare in emerging and developed countries. Baxter’s employees worldwide are building upon the company’s rich heritage of medical breakthroughs to advance the next generation of healthcare innovations that facilitate patient care.